alexa [Abuse pattern of analgesics in chronic daily headache: a study in the general population]. or = 15 days a month, those individuals (n = 332) that report subjective consumption of analgesics for headache > or = 10 days in this period filled out a headache diary for one month. A total of 72 individuals fulfilled CHA criteria (1.48\% of the general population). The varieties of CHA were classified according to the Silberstein et al criteria. RESULTS: The greatest consumption corresponded to the simple analgesic group with 34.7\% of all the subjects followed by those of combined analgesics and ergotaminics consumed by 27.8\% and 22.2\% respectively. A total of 12.5\% took opioids alone or associated and triptans were in the fifth place. The latter were consumed by 2.8\% of all the subjects. The active ingredients used most were: paracetamol (54\%), caffeine (49\%), ergotic derivatives (38\%) and propyphenazone (35\%). The subjects detected consumed a mean of 2.5 active ingredients simultaneously. The mean units consumed in their different presentation by the subjects with CHA was 50 units/month. CONCLUSIONS: This study shows that CHA is a significant health care problem. In our setting, 85\% of the persons with CHA of the population used analgesics and/or ergotics. These medications were given without prescription so that their obtention should be regulated in the pharmacy offices."/>
Pediatrics

Pediatrics

Maternal and Pediatric Nutrition

Author(s): Cols Chacartegui R, Temprano Gonzlez R, Gmez Arruza C, Muoz Cacho P, Pascual Gmez J

Abstract Share this page

Abstract BACKGROUND AND OBJECTIVE: The abuse pattern of analgesics is not well known in persons with "chronic daily headache and analgesic abuse" (CHA) in the general population. The objective of this study was to know the type of analgesics used by pharmacological group and the active ingredient in subjects with CHA in a large sample of the general population. PATIENTS AND METHODS: A questionnaire was distributed that investigated the frequency of headache and analgesic consumption among persons over 14 years (9,984 inhabitants) of the semiurban population of Santoña (Cantabria). A total of 4,855 subjects filled out the questionnaire. Although the CHA criteria require headache > or = 15 days a month, those individuals (n = 332) that report subjective consumption of analgesics for headache > or = 10 days in this period filled out a headache diary for one month. A total of 72 individuals fulfilled CHA criteria (1.48\% of the general population). The varieties of CHA were classified according to the Silberstein et al criteria. RESULTS: The greatest consumption corresponded to the simple analgesic group with 34.7\% of all the subjects followed by those of combined analgesics and ergotaminics consumed by 27.8\% and 22.2\% respectively. A total of 12.5\% took opioids alone or associated and triptans were in the fifth place. The latter were consumed by 2.8\% of all the subjects. The active ingredients used most were: paracetamol (54\%), caffeine (49\%), ergotic derivatives (38\%) and propyphenazone (35\%). The subjects detected consumed a mean of 2.5 active ingredients simultaneously. The mean units consumed in their different presentation by the subjects with CHA was 50 units/month. CONCLUSIONS: This study shows that CHA is a significant health care problem. In our setting, 85\% of the persons with CHA of the population used analgesics and/or ergotics. These medications were given without prescription so that their obtention should be regulated in the pharmacy offices.
This article was published in Rev Clin Esp and referenced in Maternal and Pediatric Nutrition

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version